Tauri Group has secured four task orders to provide additional support services for the US Department of Defense’s (DoD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND).
The orders have been awarded within the JPEO-CBRND on the Joint Enterprise Omnibus Program Engineering and Technical Support (OPETS).
The company will continue to deliver its work on two medical task orders and has received an additional task order in each of the logistics and acquisition business areas.
The orders have a combined value of approximately $60m. The JPEO-CBD is acting as the lifecycle manager for chemical, biological, radiological, and nuclear (CBRN) defence products deployed by the military.
Asymmetric Threat Division director John David said: “Tauri’s acquisition, logistics, and medical domain expertise will continue to support the JPEO-CBRND’s efforts toward advanced development and fielding of critical CBRNE technologies.
“In the rapidly changing technology environment, Tauri is providing expertise, combined with experience and passion for the JPEO mission, to accelerate timelines and get products to the warfighters.”
The company has been delivering professional services in support of the JPEO-CBRND in the areas of pharmaceutical assessment, medical countermeasures development, and life sciences research for more than a decade.
Tauri’s subject matter experts have diverse, technical skillsets to provide science and technology support in a range of specialities in addition to delivering integrated capabilities on time and within budget.